Physician profile
Robert Dow Hoffman
NPI 1558325241
$5,005.31
in general payments reported to CMS, 2019-2025
10 companies · $806 in 2025
The $806 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $2,526 · 2021: $43.42 · 2022: $64.76 · 2023: $1,448 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,239 · Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,238.57 |
| Food and Beverage | $1,015.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $1,606.75 | 2020-2025 | |
| Stryker Corporation | $1,526.00 | 2023-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Arthrex, INC. | $1,373.21 | 2020 | |
| Depuy Synthes Sales INC. | $179.71 | 2020-2025 | Fms Duo, Dynacord, N/A |
| Boston Scientific Corporation | $137.69 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $58.11 | 2021-2025 | N/A |
| Biorez, INC. | $49.84 | 2022 | |
| Anika Therapeutics, INC. | $47.52 | 2021-2023 | Tactoset |
| Novo Nordisk INC | $14.92 | 2022 | |
| Dynasplint Systems INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.